Reply to Horowitz
- 9 February 2018
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (3) , 482
Abstract
Daniel M Musher, Michael S Abers, John G Bartlett; Reply to Horowitz, Clinical Infectious Diseases, , ciy124, https://doi.org/10.1093/cid/ciy124Keywords
This publication has 7 references indexed in Scilit:
- Reconsidering Treatment of Community-Acquired Pneumonia: Are Macrolides Plus β-Lactams Essential?Clinical Infectious Diseases, 2018
- Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of PneumococcusClinical Infectious Diseases, 2017
- Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015Eurosurveillance, 2015
- Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysisInternational Journal of Antimicrobial Agents, 2015
- β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2014
- Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2012
- Rising Rates of Macrolide-Resistant Mycoplasma pneumoniae in the Central United StatesThe Pediatric Infectious Disease Journal, 2012